IBM, US4592001014

UBS keeps IBM Neutral at USD 236 target. IBM stock trades 1.88 percent below Xetra close

Published on 10/15/2026 at 11:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 1.10 percent to USD 17.16 billion. IBM stock costs EUR 203.80 on October 15, 2026 versus the EUR 207.70 Xetra close.

Analyst caution and reporting date

  • UBS reiterated a Neutral rating and a USD 236.00 target on October 13, 2026.
  • Second-quarter revenue reached USD 17.16 billion, up 1.10 percent year over year.
  • IBM stock trades at EUR 203.80 at 11:00 a.m. CEST at Lang & Schwarz on October 15, 2026, 1.88 percent below the Xetra close of October 14, 2026.
Editorial stock trading floor photograph with large wall-mounted monitors displaying sector labels ENTERPRISE IT, CLOUD, QUANTUM, and NYSE in bold white text on dark screens, with financial line charts and data grids below, traders seated at workstations
IBM Börsensaal Monitore zeigen ENTERPRISE IT CLOUD QUANTUM NYSE und neutrale Charts US4592001014, Illustration mit AI erstellt.

IBM (ISIN US4592001014) was trading at EUR 203.80 at Lang & Schwarz on October 15, 2026 at 11:00 a.m. CEST, 1.88 percent below the Xetra close of October 14, 2026 at EUR 207.70. According to Investing.com on October 13, 2026, UBS reiterated a Neutral rating and a USD 236.00 price target for IBM. The assessment puts execution and delayed deals ahead of the company's quantum-computing ambitions.

Three events shape the story

On July 22, 2026, IBM reported second-quarter revenue of USD 17.16 billion, up 1.10 percent from the prior year, while adjusted earnings per share reached USD 2.93 against consensus of USD 2.93, according to MarketBeat. On October 7, 2026, IBM announced selection for Stage C of the DARPA Quantum Benchmarking Initiative, with the company expecting its first fault-tolerant system in 2029, according to IBM. On October 13, 2026, UBS maintained its USD 236.00 target, according to Investing.com.

What does the target imply?

UBS cited limited recovery of delayed contracts and supply constraints. The firm said IBM had recaptured less than 50 percent of deals that slipped from the second quarter, while its calendar third-quarter revenue forecast stood at USD 16.678 billion versus Visible Alpha consensus of USD 16.798 billion, as Investing.com reported. That gap makes the next report a test of whether delayed demand converts into recognized revenue.

When does IBM report next?

IBM is scheduled to announce third-quarter 2026 financial results on October 21, 2026, with the earnings call at 5:00 p.m. ET, according to IBM. The release will give investors a fresh read on software growth, delayed contracts and the revenue outlook.

IBM stock stays below the close

The EUR 203.80 Lang & Schwarz quote sits EUR 3.90 below the EUR 207.70 Xetra close of October 14, 2026. For investors, the October 21 results date and the USD 236.00 UBS target frame the near-term debate around IBM's execution.

The further course of trading is shown by the continuously updated real-time quote of IBM stock.

IBM stock facts

  • Company: International Business Machines Corporation
  • ISIN: US4592001014
  • Ticker: IBM
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 15, 2026, 11:00 a.m. CEST): EUR 203.80
  • Change versus Xetra close: minus 1.88 percent
  • Xetra close (October 14, 2026): EUR 207.70
  • Market capitalization: USD 214.7 billion (as of October 14, 2026)
  • Sector / Industry: Technology / Information Technology Services

Market context: Market report S&P 500.

More news and analyses on IBM stock

Disclaimer...

en | US4592001014 | IBM | boerse | 70327879 | bgmi